AbbVie與中國FutureGen簽署高達17億美元的藥物授權協議；中國缺席烏克蘭和平峰會引發爭議；特斯拉股價飆升，馬斯克560億美元薪酬計劃獲支持：華爾街電視簡報20240613

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.